We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
E-therapeutics Plc | LSE:ETX | London | Ordinary Share | GB00B2823H99 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.40 | -13.66% | 8.85 | 8.60 | 9.05 | 9.55 | 9.00 | 9.55 | 3,758,132 | 16:35:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 475k | -8.27M | -0.0142 | -6.34 | 52.55M |
TIDMETX TIDMAV.
RNS Number : 0578H
e-Therapeutics plc
02 June 2017
For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) ----------------------------------------------------------------------------------------------------- 1. Identity of the issuer or e-Therapeutics plc the underlying issuer of existing shares to which voting rights are attached: (ii) ----------------------------------------------------------------- ---------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ----------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights -------------------------------------------------------------------- ------------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached -------------------------------------------------------------------- ------------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments -------------------------------------------------------------------- ------------------------------- An event changing the breakdown of voting rights -------------------------------------------------------------------- ------------------------------- Other (please specify): ----------------------------------------------------------- ------- ------------------------------- 3. Full name of person(s) Aviva plc & its subsidiaries subject to the notification obligation: (iii) ------------------------------------------------------------- -------------------------------------- 4. Full name of shareholder(s) N/A (if different from 3.):(iv) ------------------------------------------------------------- -------------------------------------- 5. Date of the transaction 01 June 2017 and date on which the threshold is crossed or reached: (v) ------------------------------------------------------------- -------------------------------------- 6. Date on which issuer 02 June 2017 notified: ------------------------------------------------------------- -------------------------------------- 7. Threshold(s) that is/are 15% to <5% Change at Combined crossed or Interest Level AND 15% to reached: (vi, vii) <3% Change at Direct Interest Level ------------------------------------------------------------- -------------------------------------- 8. Notified details: -------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) -------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE -------------------- -------------------------------- ------------------------------------------------------ Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights -------------------- ------------------- ----------- ------------ ------------------- ------------------- Direct Direct Indirect Direct Indirect (xi) (xii) -------------------- ------------------- ----------- ------------ ------- ---------- ------- ---------- Ordinary Shares GB00B2823H99 42,542,868 42,542,868 Nil Nil Nil Nil Nil ------------------- ----------- ------------ ------- ---------- ------- ---------- B: Qualifying Financial Instruments -------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction -------------------------------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of voting % of voting instrument date Conversion rights that rights (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. -------------------- ------------------- ------------------------- ------------------- ------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ----------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------- Type of financial Exercise Expiration Exercise/ Number of voting % of voting instrument price date Conversion rights instrument rights (xix, (xvii) period refers to xx) (xviii) ------------------ --------- ----------- ------------ ------------------- ---------------- Nominal Delta ------------------ --------- ----------- ------------ ------------------- -------- ------ Total (A+B+C) ------------------------------------------------------- Number of voting rights Percentage of voting rights ------------------------- ---------------------------- Nil 0% ------------------------- ---------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) -------------------------------------------------------------------------- Proxy Voting: -------------------------------------------------------------------------- 10. Name of the proxy holder: See Section 4 --------------------------------------------- --------------------------- 11. Number of voting rights proxy holder will cease to hold: --------------------------------------------- --------------------------- 12. Date on which proxy holder will cease to hold voting rights: --------------------------------------------- --------------------------- 13. Additional information: --------------------------------------------- --------------------------- 14. Contact name: Michael Dunhill, Aviva plc --------------------------------------------- --------------------------- 15. Contact telephone number: 01603 685988 --------------------------------------------- ---------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLLFLSRRIFIID
(END) Dow Jones Newswires
June 02, 2017 10:19 ET (14:19 GMT)
1 Year E-therapeutics Chart |
1 Month E-therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions